Pulike Biological Engineering (603566.SHG)

Pulike Biological Engineering stock price today, ATLAS forecast and fair value

Healthcare · Biotechnology · Shanghai Stock Exchange · China

CN¥9.37▼ -8.76%

Prices as of Oct 27, 2026 · CNY

ATLAS fair value

CN¥11.62

Below fair value · 19% discount

Chance of rising in 1 month

51%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Pulike Biological Engineering in ATLAS

ATLAS's own quantitative analysis, all in one place.

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
See everything included
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.

On Pulike Biological Engineering

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.

And for you

  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.
Get started →

Plans from €3.99 a month.

ATLAS estimates Pulike Biological Engineering's fair value at about CN¥11.62 per share (reasonable range: CN¥9.06 to CN¥14.75). At CN¥9.37, the stock trades 19% below it.

It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.

ATLAS's model gives Pulike Biological Engineering a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between CN¥8.94 and CN¥9.87; in 9 out of 10, between CN¥8.18 and CN¥10.78. Estimated annual volatility is 27%.

Price, last 12 months (weekly close)

Pulike Biological Engineering (603566.SHG) — Price, last 12 months (weekly close)Oct 24, 2025: CN¥14.07. Oct 27, 2026: CN¥9.37. ▼Fair value CN¥11.62CN¥14.42CN¥9.37Oct 24, 2025Oct 27, 2026

Key numbers

Market cap
CN¥3.5B
Market cap (USD)
$522M
P/E ratio
23.4
Dividend yield
3.98%
52-week high
CN¥14.58
52-week low
CN¥9.35
Revenue (12 months)
CN¥1.0B
Gross margin
57.9%
Operating margin
8.2%
Net margin
14.3%
Beta
0.32

What this means

These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Pulike Biological Engineering sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.

Over the last 52 weeks 603566.SHG has traded between CN¥9.35 and CN¥14.58. Today it is 35.7% below that high and 0% above its low.

On the business: net margin is 14.3%; it trades at 23.4 times earnings.

Its beta is 0.32: it tends to move less than the market.

About the company

Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for livestock, poultry, and pets.

Want to see everything about Pulike Biological Engineering?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What is Pulike Biological Engineering (603566.SHG) fair value?

About CN¥11.62 per share according to ATLAS (reasonable range: CN¥9.06 to CN¥14.75). With the stock at CN¥9.37, it is 19% below it.

What is the chance 603566.SHG goes up next month?

51%: close to a coin flip. In half of the simulated outcomes, 603566.SHG ends the month between CN¥8.94 and CN¥9.87.

How big is Pulike Biological Engineering and what is its P/E ratio?

Pulike Biological Engineering's market capitalization is CN¥3.5B. Its price-to-earnings (P/E) ratio is 23.4: you pay CN¥23.4 for each CN¥1.00 of yearly earnings.

Does Pulike Biological Engineering pay a dividend?

Yes. 603566.SHG's current dividend yield is 3.98% at today's price (CN¥9.37).

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy